Evidence map›Paper›PMID 39624166›Full record

ArticleComputational and structural biotechnology journal2024

Enhanced prediction of protein functional identity through the integration of sequence and structural features.

Suguru Fujita, Tohru Terada

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. AlphaFold in protein structure and function prediction.Computational and structural biotechnology journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Suguru FujitaDepartment of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Tohru TeradaDepartment of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although over 300 million protein sequences are registered in a reference sequence database, only 0.2 % have experimentally determined functions. This suggests that many valuable proteins, potentially catalyzing novel enzymatic reactions, remain undiscovered among the vast number of function-unknown proteins. In this study, we developed a method to predict whether two proteins catalyze the same enzymatic reaction by analyzing sequence and structural similarities, utilizing structural models predicted by AlphaFold2. We performed pocket detection and domain decomposition for each structural model. The similarity between protein pairs was assessed using features such as full-length sequence similarity, domain structural similarity, and pocket similarity. We developed several models using conventional machine learning algorithms and found that the LightGBM-based model outperformed the models. Our method also surpassed existing approaches, including those based solely on full-length sequence similarity and state-of-the-art deep learning models. Feature importance analysis revealed that domain sequence identity, calculated through structural alignment, had the greatest influence on the prediction. Therefore, our findings demonstrate that integrating sequence and structural information improves the accuracy of protein function prediction.

Indexed as

Domain decompositionFeature importanceMachine learningProtein function predictionSequence similarityStructural similarity

Identifiers

PMID39624166
PMCPMC11609699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.